Christopher W. Cain

Insider Reports History

Entity
Individual
Location
2001 Market Street, Suite 2500, Philadelphia, PA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher W. Cain:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Director Stock Option (Right to Buy) 44.7K Jun 5, 2024 Direct

Insider Reports Filed by Christopher W. Cain

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COGT Cogent Biosciences, Inc. Jun 5, 2024 1 $0 4 Jun 13, 2024 Director
COGT Cogent Biosciences, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
COGT Cogent Biosciences, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director